EMA - Nuovi farmaci autorizzati
New medicines and opinions: human
-
Human medicines European public assessment report (EPAR): Winlevi, clascoterone, Status: Opinion
Human medicines European public assessment report (EPAR): Winlevi, clascoterone, Status: Opinion -
Human medicines European public assessment report (EPAR): Dazublys, trastuzumab, Status: Opinion
Human medicines European public assessment report (EPAR): Dazublys, trastuzumab, Status: Opinion -
Human medicines European public assessment report (EPAR): Ziihera, zanidatamab, Status: Opinion
Human medicines European public assessment report (EPAR): Ziihera, zanidatamab, Status: Opinion -
Human medicines European public assessment report (EPAR): Denosumab BBL, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Denosumab BBL, denosumab, Status: Opinion -
Human medicines European public assessment report (EPAR): Duvyzat, givinostat, Status: Opinion
Human medicines European public assessment report (EPAR): Duvyzat, givinostat, Status: Opinion